论文部分内容阅读
本刊讯据有关报道,太阳纸业2012年8月16日连发3个公告,对旗下业务进行整合。除旗下两家纸业子公司实施整合,以及一控股子公司注册资本减少2188.16万美元(约合1.39亿元人民币)外,公司还另辟蹊径,拟以自有资金3000万元人民币设立生物科技公司,从事木糖醇相关衍生品开发。对于进行该投资的缘由,公司称是因为与相关科研院校合作,目前已掌握利用制浆过程中产生的水解液提取物生产新型木糖、木糖醇的技术,并进行了专利保护申请。为尽快将该技术用于生产,特成立新公司开展此项业务。
According to the press reports, Sun Paper August 16, 2012 issued three bulletins, its business integration. In addition to the two paper subsidiaries to implement the integration, and a subsidiary of the registered capital reduction of 21,881,600 US dollars (about 139 million yuan), the company also another way, to be its own funds 30 million yuan to set up biotechnology companies, Xylitol-related derivatives in the development. The reason for the investment, the company said it is because of the cooperation with relevant research institutes, has now grasped the use of hydrolyzed liquid extract produced in the pulping process to produce new xylose, xylitol technology, and applied for a patent protection. In order to apply this technology to production as soon as possible, we set up a new company to carry out this business.